The oral bioavailability of a pleuromutilin antibiotic candidate is increased after co-administration with the CYP3A4 inhibitor ritonavir and the P-gp inhibitor zosuquidar formulated as amorphous solid dispersions

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

17 Downloads (Pure)

Fingeraftryk

Dyk ned i forskningsemnerne om 'The oral bioavailability of a pleuromutilin antibiotic candidate is increased after co-administration with the CYP3A4 inhibitor ritonavir and the P-gp inhibitor zosuquidar formulated as amorphous solid dispersions'. Sammen danner de et unikt fingeraftryk.

Pharmacology, Toxicology and Pharmaceutical Science